KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Short-term Investments (2016 - 2025)

Sarepta Therapeutics has reported Short-term Investments over the past 13 years, most recently at $138.4 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 45.04% year-over-year to $138.4 million; the TTM value through Dec 2025 reached $138.4 million, down 45.04%, while the annual FY2025 figure was $138.4 million, 45.04% down from the prior year.
  • Short-term Investments for Q4 2025 was $138.4 million at Sarepta Therapeutics, down from $237.9 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $1.2 billion in Q4 2023 and troughed at $30.0 million in Q2 2021.
  • A 5-year average of $662.5 million and a median of $871.5 million in 2022 define the central range for Short-term Investments.
  • Biggest five-year swings in Short-term Investments: soared 3431.51% in 2022 and later crashed 96.26% in 2024.
  • Year by year, Short-term Investments stood at $30.0 million in 2021, then soared by 3308.66% to $1.0 billion in 2022, then increased by 22.02% to $1.2 billion in 2023, then plummeted by 79.82% to $251.8 million in 2024, then crashed by 45.04% to $138.4 million in 2025.
  • Business Quant data shows Short-term Investments for SRPT at $138.4 million in Q4 2025, $237.9 million in Q3 2025, and $289.5 million in Q2 2025.